Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amy E. Bulpitt"'
Autor:
Min Zhu, Jerry Jean Stambaugh, Amy E. Bulpitt, Shaun E. Berning, R. Namdar, Charles A. Peloquin, Jeffrey R. Starke
Publikováno v:
Tuberculosis. 82:91-96
Setting: Three US referral hospitals. Objective: Determine the population pharmacokinetic (PK) parameters of ethionamide (ETA) following multiple oral doses. Design: Fifty-five patients with tuberculosis (TB) participated. Patients received multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ef4fc222682125b835e1a823d18013
https://doi.org/10.1054/tube.2002.0330
https://doi.org/10.1054/tube.2002.0330
Autor:
George S. Jaresko, Amy E. Bulpitt, Roger W. Jelliffe, Charles A. Peloquin, A. C. F. Keung, C.-L. Yong
Publikováno v:
Antimicrobial Agents and Chemotherapy. 41:2670-2679
Isoniazid (INH), rifampin (RIF), and pyrazinamide (PZA) are the most important drugs for the treatment of tuberculosis (TB). The pharmacokinetics of all three drugs in the plasma of 24 healthy males were studied as part of a randomized cross-over pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e324837c087a420900c8212cee3f3d4
https://doi.org/10.1128/aac.41.12.2670
https://doi.org/10.1128/aac.41.12.2670
Autor:
Min Zhu, William J. Burman, Charles A. Peloquin, Amy E. Bulpitt, Jerry Jean Stambaugh, Jeffrey R. Starke, David Ashkin, Shaun E. Berning, Phillip Steiner
Publikováno v:
Pharmacotherapy. 22(6)
Study Objective. To determine population pharmacokinetic parameters of pyrazinamide after multiple oral doses given to children and adults with tuberculosis. Design. Prospective, multiple-dose population pharmacokinetic study. Setting. Five hospitals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6590d45ae136791b3425ad2ea28c71a8
https://pubmed.ncbi.nlm.nih.gov/12066959
https://pubmed.ncbi.nlm.nih.gov/12066959
Autor:
Charles A. Peloquin, Amy E. Bulpitt, George S. Jaresko, David E. Nix, Roger W. Jelliffe, James M. Childs
Publikováno v:
Antimicrobial agents and chemotherapy. 43(3)
Ethambutol (EMB) is the most frequent “fourth drug” used for the empiric treatment of Mycobacterium tuberculosis and a frequently used drug for infections caused by Mycobacterium avium complex. The pharmacokinetics of EMB in serum were studied wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54248bc94ccd2e2e89f5d7aabaed0a4d
https://pubmed.ncbi.nlm.nih.gov/10049268
https://pubmed.ncbi.nlm.nih.gov/10049268